Relapse in the skull after myeloablative therapy for high-risk neuroblastoma

Pediatric Hematology and Oncology

Volumn 20, Issue 1, 2003, Pages 23-30

  Sangthawan, D ^a,c   DesRosiers, P M ^a   Randall, M E ^a   Robertson, K ^b   Goebel, S ^b   Fallon, R ^b  

^a INDIANA UNIVERSITY   (United States)

^b RILEY CHILDREN S HOSPITAL   (United States)

^c Indiana Cancer Pavilion   (United States)

Author keywords

Neuroblastoma; Radiation; Stem cell transplantation

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; ISOTRETINOIN; MELPHALAN; VINCRISTINE;

ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NEUROBLASTOMA; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; WHOLE BODY RADIATION;

EID: 0037215871     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010390158504     Document Type: Article

References (19)

1. Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Curr Opin Oncol. 1998;10:43-51.
2. Lodenstein R, Philip T, Lasset C, Hartmann O, Garaventa A, Pinkerton R. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem cell transplantation: A report from the European bone marrow transplantation solid tumor registry. J Clin Oncol. 1998;16:953-963.
3. Matthay KK. Neuroblastoma. In: Pochedly C, ed. Neoplastic Diseases of Childhood. Chur, Switzerland: Harwood Academic; 1994:735-778.
4. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, Ed. 2. Philadelphia: Lippincott; 1993:739-767.
5. Matthay KK, Castleberry PP. Treatment of advanced neuroblastoma: The US experience. In: Brodeur GM, Sawada T, eds. Neuroblastoma. Elsevier Science B.V.; 2000:417-436.
6. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK. Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retinoic acid. N Engl J Med. 1999;341:1165-1173.
7. Pinkerton CR, Pritchard J, Dekvaker J. ENSG 1-randomized study of high dose melphalan in neuroblastoma. In: Dicke KA, Spitzer G, Jagannath S, eds. Autologous Bone Marrow Transplantation. Houston, TX: University of Texas Press; 1987:401-410.
8. Berthold F, Burdach S, Kresmens B. The role of chemotherapy in treatment of children with neuroblastoma stage 4: The GPO (German Pediatric Oncology Society) experience. Klin Padiatr. 1990;202:262-269.
9. Bowman LC, Hancock ML, Santana VM. Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: The St Jude Children's Research Hospital experience, 1962 to 1988. J Clin Oncol. 1991;9:1599-1608.
10. Suita S, Zaizen Y, Kaneko M. What is the benefit of aggressive chemotherapy for advanced neuroblatoma with N-myc amplification? A report from the Japanese study group for the treatment of advanced neuroblastoma. J Pediatr Surg. 1994;29:746-750.
11. Matthay KK, Seegar RC, Reynolds CP. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: A report from the Children's Cancer Group. J Clin Oncol. 1994;12:2382-2389.
12. Seegar RC, Reynolds CP. Treatment of high risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am. 1991;38:393-424.
13. Cheeng NV, Heller G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in meatastatic neuroblastoma. J Clin Oncol. 1991;9:1050-1058.
14. Kushner BH, Rilly RJ, Mandell LR. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol. 1991;9:274-279.
15. Seegar RC, Villablanea JG, Matthay KK. Intensive chemotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res. 1991;366:527-533.
16. Kushner BH, Wolden S, Laquaglia MP, Kramer K, Verbel D, Heller G. Hyperfractionated low-dose radiotherapy for high risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol. 2001;19:2821-2828.
17. Wolden SL, Gollamudi SV, Kushner BH, et al. Local control with multimodality therapy for stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys. 2000;46:969-974.
18. Rosen E, Cassady JR, Frantz CN, Kretschmar C, Levey R, Sallan S. Neuroblastoma: The Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital Experience. J Clin Oncol. 1984;2:719-732.
19. Ikeda H, August CS, Goldwein JW, Evans AE. Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory "Debulking" treatments. J Pediatr Surg. 1992;27:1438-1441.